257 related articles for article (PubMed ID: 9836378)
1. Biological insights from clinical trials with anti-TNF therapy.
Feldmann M; Charles P; Taylor P; Maini RN
Springer Semin Immunopathol; 1998; 20(1-2):211-28. PubMed ID: 9836378
[No Abstract] [Full Text] [Related]
2. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?
Feldmann M; Maini RN
Annu Rev Immunol; 2001; 19():163-96. PubMed ID: 11244034
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha-targeted therapy in rheumatoid arthritis.
Wendling D; Toussirot E
Rev Rhum Engl Ed; 1999 Apr; 66(4):187-91. PubMed ID: 10339773
[No Abstract] [Full Text] [Related]
4. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
Fautrel B; Cherin P
Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
[TBL] [Abstract][Full Text] [Related]
5. [Role of anti-TNF therapy in rheumatoid arthritis].
Meyer O
Presse Med; 2000 Mar; 29(9):463-8. PubMed ID: 10745935
[TBL] [Abstract][Full Text] [Related]
6. National Meeting of the American College of Rheumatology. November 8-12, 1998, San Diego, California.
Badii M
Clin Invest Med; 1999 Apr; 22(2):63-4. PubMed ID: 10340106
[No Abstract] [Full Text] [Related]
7. Cytokines in rheumatoid arthritis: trials and tribulations.
Carteron NL
Mol Med Today; 2000 Aug; 6(8):315-23. PubMed ID: 10904249
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases.
Feldman M; Taylor P; Paleolog E; Brennan FM; Maini RN
Transplant Proc; 1998 Dec; 30(8):4126-7. PubMed ID: 9865320
[No Abstract] [Full Text] [Related]
9. [62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998].
Cherin P
Rev Med Interne; 1999 Apr; 20(4):311-7. PubMed ID: 10327473
[No Abstract] [Full Text] [Related]
10. [Cytokines and anti-cytokine therapy in rheumatoid arthritis].
Lorenz HM; Kalden JR
Internist (Berl); 2001 Jan; 42(1):55-6, 59-63. PubMed ID: 11271621
[No Abstract] [Full Text] [Related]
11. [Recombinant proteins or monoclonal antibodies: comparative properties and interest in rheumatoid arthritis].
Sibilia J
Med Sci (Paris); 2009 Dec; 25(12):1033-8. PubMed ID: 20035675
[TBL] [Abstract][Full Text] [Related]
12. [Anti-TNF alpha in rheumatoid arthritis].
Schreiber S; Sternon J
Rev Med Brux; 2001 Jun; 22(3):174-80. PubMed ID: 11488086
[TBL] [Abstract][Full Text] [Related]
13. TNF inhibitors: a new age in rheumatoid arthritis treatment.
Anderson DL
Am J Nurs; 2004 Feb; 104(2):60-8; quiz 68-9. PubMed ID: 14767382
[No Abstract] [Full Text] [Related]
14. TNF-alpha inhibition: the need for a tumor necrosis factor thermostat.
O'Dell JR
Mayo Clin Proc; 2001 Jun; 76(6):573-5. PubMed ID: 11393494
[No Abstract] [Full Text] [Related]
15. [Therapeutic efficacy and the adverse effects of newly developed biological agents for rheumatoid arthritis].
Kondo H
Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):153-60. PubMed ID: 14968591
[No Abstract] [Full Text] [Related]
16. [TNF targetting therapy for rheumatoid arthritis].
Takeuchi T
Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1787-94. PubMed ID: 17037316
[No Abstract] [Full Text] [Related]
17. How many patients are eligible for anti-TNF therapy in the UK?
Douglas K; Bowman SJ
Rheumatology (Oxford); 2001 Dec; 40(12):1416. PubMed ID: 11752515
[No Abstract] [Full Text] [Related]
18. Treatment of rheumatoid arthritis by TNF-blocking agents.
Graninger W; Smolen J
Int Arch Allergy Immunol; 2002 Jan; 127(1):10-4. PubMed ID: 11893849
[TBL] [Abstract][Full Text] [Related]
19. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
González-Gay MA; Agudo M
Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
[No Abstract] [Full Text] [Related]
20. [Anti-TNF therapy in rheumatoid arthritis].
Yakeuchi T; Amano K
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Feb; 27(1):7-15. PubMed ID: 15045810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
